166 related articles for article (PubMed ID: 26352795)
21. Recent advances in β-catenin/BCL9 protein-protein interaction inhibitors.
Zhang H; Bao Y; Liu C; Li J; Zhu D; Zhang Q
Future Med Chem; 2021 May; 13(10):927-940. PubMed ID: 33849283
[TBL] [Abstract][Full Text] [Related]
22. Small molecule modulators of Wnt/β-catenin signaling.
Mook RA; Chen M; Lu J; Barak LS; Lyerly HK; Chen W
Bioorg Med Chem Lett; 2013 Apr; 23(7):2187-91. PubMed ID: 23453073
[TBL] [Abstract][Full Text] [Related]
23. Exploring key orientations at protein-protein interfaces with small molecule probes.
Ko E; Raghuraman A; Perez LM; Ioerger TR; Burgess K
J Am Chem Soc; 2013 Jan; 135(1):167-73. PubMed ID: 23270593
[TBL] [Abstract][Full Text] [Related]
24. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
[TBL] [Abstract][Full Text] [Related]
25. Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.
McCoy MA; Spicer D; Wells N; Hoogewijs K; Fiedler M; Baud MGJ
J Med Chem; 2022 May; 65(10):7246-7261. PubMed ID: 35581674
[TBL] [Abstract][Full Text] [Related]
26. Glutamine Synthetase Drugability beyond Its Active Site: Exploring Oligomerization Interfaces and Pockets.
Moreira C; Ramos MJ; Fernandes PA
Molecules; 2016 Aug; 21(8):. PubMed ID: 27509490
[TBL] [Abstract][Full Text] [Related]
27. Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based Methods.
Kessler D; Mayer M; Zahn SK; Zeeb M; Wöhrle S; Bergner A; Bruchhaus J; Ciftci T; Dahmann G; Dettling M; Döbel S; Fuchs JE; Geist L; Hela W; Kofink C; Kousek R; Moser F; Puchner T; Rumpel K; Scharnweber M; Werni P; Wolkerstorfer B; Breitsprecher D; Baaske P; Pearson M; McConnell DB; Böttcher J
ChemMedChem; 2021 May; 16(9):1420-1424. PubMed ID: 33275320
[TBL] [Abstract][Full Text] [Related]
28. Decoding the dynamics of BCL9 triazole stapled peptide.
Gaikwad V; Choudhury AR; Chakrabarti R
Biophys Chem; 2024 Apr; 307():107197. PubMed ID: 38335808
[TBL] [Abstract][Full Text] [Related]
29. A Review of Stapled Peptides and Small Molecules to Inhibit Protein-Protein Interactions in Cancer.
Iyer VV
Curr Med Chem; 2016; 23(27):3025-3043. PubMed ID: 27356541
[TBL] [Abstract][Full Text] [Related]
30. Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives.
Wang Z; Li Z; Ji H
Med Res Rev; 2021 Jul; 41(4):2109-2129. PubMed ID: 33475177
[TBL] [Abstract][Full Text] [Related]
31. Design of triazole-stapled BCL9 α-helical peptides to target the β-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction.
Kawamoto SA; Coleska A; Ran X; Yi H; Yang CY; Wang S
J Med Chem; 2012 Feb; 55(3):1137-46. PubMed ID: 22196480
[TBL] [Abstract][Full Text] [Related]
32. Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors.
Li B; Rong D; Wang Y
Curr Top Med Chem; 2019; 19(21):1872-1876. PubMed ID: 31696799
[TBL] [Abstract][Full Text] [Related]
33. Protein Domain Mimics as Modulators of Protein-Protein Interactions.
Sawyer N; Watkins AM; Arora PS
Acc Chem Res; 2017 Jun; 50(6):1313-1322. PubMed ID: 28561588
[TBL] [Abstract][Full Text] [Related]
34. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
[TBL] [Abstract][Full Text] [Related]
35. Bicyclic β-Sheet Mimetics that Target the Transcriptional Coactivator β-Catenin and Inhibit Wnt Signaling.
Wendt M; Bellavita R; Gerber A; Efrém NL; van Ramshorst T; Pearce NM; Davey PRJ; Everard I; Vazquez-Chantada M; Chiarparin E; Grieco P; Hennig S; Grossmann TN
Angew Chem Int Ed Engl; 2021 Jun; 60(25):13937-13944. PubMed ID: 33783110
[TBL] [Abstract][Full Text] [Related]
36. Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.
Algar S; Martín-Martínez M; González-Muñiz R
Eur J Med Chem; 2021 Feb; 211():113015. PubMed ID: 33423841
[TBL] [Abstract][Full Text] [Related]
37. Peptide-Directed Binding for the Discovery of Modulators of α-Helix-Mediated Protein-Protein Interactions: Proof-of-Concept Studies with the Apoptosis Regulator Mcl-1.
Beekman AM; O'Connell MA; Howell LA
Angew Chem Int Ed Engl; 2017 Aug; 56(35):10446-10450. PubMed ID: 28670766
[TBL] [Abstract][Full Text] [Related]
38. Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.
Sable R; Jois S
Molecules; 2015 Jun; 20(6):11569-603. PubMed ID: 26111183
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of protein-protein interaction complexes through small molecules.
Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of α-helix-mediated protein-protein interactions using designed molecules.
Azzarito V; Long K; Murphy NS; Wilson AJ
Nat Chem; 2013 Mar; 5(3):161-73. PubMed ID: 23422557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
